PACER – A multicentre, single-arm, two-stage, phase 2 study of panitumumab in patients with cetuximab-refractory metastatic colorectal cancer (mCRC)Bruno Daniele, Maria Carmela Piccirillo, C. Chiara et al.|Annals of Oncology|2016Cited by 1